Trial intelligence / Profile preview

Stannous Fluoride Toothpaste for Induced Gingivitis

NCT05731778Phase 4Completed

Sponsor
Colgate-Palmolive
Start
Dec 2018
Primary completion
Dec 2020
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of stannous fluoride in gingivitis (2 arms), sponsored by Colgate-Palmolive. Primary endpoints: Bleeding Index (BOP) at 9 weeks and Oral Inflammatory Load at 9 weeks. Started Dec 2018; status: completed.

02

Drugs

stannous fluoride
03

Conditions

gingivitis

Beyond the preview

Go deeper on NCT05731778.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05731778.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call